Clinical Trial Update: Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of PSMA-targeted designer T cells in advanced prostate cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Anti-PSMA Designer T Cells (PSMA-targeted T cells (designer))

Snippet

Sponsor: Roger Williams Medical Center | Conditions: Monitor Adverse Events | Phase 1, Phase 2 | Status: SUSPENDED